Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2020-2025

SKU ID : QYR-15203277 | Publishing Date : 13-Feb-2020 | No. of pages : 103

In 2019, the global Induced Pluripotent Stem Cells market size was 80.52 million US$ and it is expected to reach 160.91 million US$ by the end of 2025, with a CAGR of 12.26% during 2020-2025.

This report focuses on the global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions

The key players covered in this study

Fujifilm Holding Corporation (CDI)
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology

Market segment by Type, the product can be split into

Human iPSCs
Mouse iPSCs

Market segment by Application, split into

Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine

Market segment by Regions/Countries, this report covers

United States
Southeast Asia
Central & South America
Other Regions

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports